Clinical Trial Update: A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating how inhaled fluticasone propionate affects bronchial responsiveness to leukotriene D4 in patients with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma, Mild Asthma | Phase 4 | Status: COMPLETED